A focused transcriptomic analysis of the TP53-regulated genes identifies the GPI-anchored molecule-like protein(GML)as a favorable prognostic predictor of lung cancer  

作　　者：Yutong Wang Shanshan Wang Yanmei Cui Jie Zhang Shuang Geng Honglei Yin Simiao Zhang Qiufang Li Yunliang Wang 

机构地区：[1]School of Public Health and Laboratory of Qilu Medical University,Zibo,Shandong 255300,China [2]School of Nursing and Health of Zhengzhou University,Zhengzhou,Henan 450052,China [3]Department of Neurology,960th Hospital of PLA,Zibo,Shandong 255300,China [4]Department of Neurology,The Second Affiliated Hospital of Zhengzhou University,Zhengzhou,Henan 450014,China [5]Shangqiu Medical College,Shangqiu,Henan 476100,China

出　　处：《Genes & Diseases》2023年第2期396-398,共3页基因与疾病（英文）

基　　金：supported in part by a research grant from the Shandong Natural Science Foundation(No.ZR2019MH065).

摘　　要：Lung cancer is the most common cause of cancer-related mortality worldwide.1 The current clinical staging systems cannot adequately predict the prognosis of patients with lung cancer,making it difficult to individualize the clinical treatment of the disease,resulting in poorer outcomes.

关 键 词：lung clinical mortality 

分 类 号：R734.2[医药卫生—肿瘤]